November 16 is a Saturday. If topline is positive it could make for an even more ‘interesting’ market opening on Monday, November 18 should the numbers support a strong trial result. Ideally I suppose that would be a RRR% that blows the doors off the CV death component (is that like a 1 pt. MACE?) and improvement in eGFR and MoCA numbers in whatever way that is significant. It’s all a lot to ask for, but that’s why we’re all here biting our nails. :)